Fintel reports that on May 1, 2025, UBS upgraded their outlook for Revvity (NYSE:RVTY) from Neutral to Buy. Analyst Price ...

Revvity ( NYSE:RVTY ) First Quarter 2025 Results Key Financial Results Revenue: US$664.8m (up 2.3% from 1Q 2024). Net... Revvity Inc (RVTY) reports a robust Q1 2025 performance, exceeding EPS ...

Piotr Swat / SOPA Images / LightRocket via Getty Images Revvity reported first-quarter earnings that topped analysts' estimates. Revenue rose in both of the biotech company's two segments.

WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Revvity, Inc. (RVTY) on Monday reported first-quarter earnings of $42.2 million. On a per-share basis, the Waltham, Massachusetts-based company said ...

Revvity (NYSE:RVTY) will release its quarterly earnings report on Monday, 2025-04-28. Here's a brief overview for investors ahead of the announcement. Analysts anticipate Revvity to report an ...

Life sciences company Revvity (NYSE:RVTY) will be reporting results tomorrow before market hours. Here’s what investors should know. Revvity met analysts’ revenue expectations last quarter ...

Shares of Revvity Inc. RVTY shed 1.23% to $92.83 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.64% to 5,650.38 and ...